Presentation is loading. Please wait.

Presentation is loading. Please wait.

Valve Replacement in Infective Endocarditis

Similar presentations


Presentation on theme: "Valve Replacement in Infective Endocarditis"— Presentation transcript:

1 Valve Replacement in Infective Endocarditis
PJA Slabbert Cardiology

2 Patient history 34 year male from NC
Admitted KHC : 23/3/10 to 8/4/10 for Infective Endocarditis (culture negative) Pen G and Gentamycin Clinically deteriorated over 3 days and follow up echocardiogram showed: Worsening heart failure More extensive vegetations on aorta valves

3 Systemic enquiry: Previous medical Hx:
Neurology: no TIA, no amurosis fugax Respiratory: 3 weeks non productive cough, progressive dyspnoea Cardiology: Angina on exertion, ortopnea, PND, dyspnoea NYHA grade 4, ankle swelling, no sharp chest pain radiating to back. Gastro-enterology: vomited previous night. Previous medical Hx: D-E-A-T-H-, not known with cardiac condition, no chronic medication

4 Examination General: Chronically ill: underweight J-A-C-C-O+L-
BP 121/52 (no cardiogenic shock, wide pulse pressure), HR 92/m, normal temperature, RR 33/m, saturation 98% on 40% oxygen Diffuse fungal/ yeast skin infection: Pityriasis versicolor No peripheral manifestations of infective endocarditis: Roth spots, subungual hemorrhages, Janeway lesions

5 Cardiovascular Water hammer pulse, equal pulses and BP left and right. Elevated JVP 2cm above baseline Apex displaced inferior lateral: 6th ics aal Loud P2, C3 both ventricles Decrescendo diastolic murmur parasternally with ejection systolic murmur not radiating. No Austin Flint

6 Respiratory: Abdomen: Urine Dipstix : Diffuse inspiratory crackles
Distressed : tachypnoea, accessory muscle use. Abdomen: No Hepatomegaly, No splenomegaly Urine Dipstix : no microscopic hematuria

7 Problem List Infective Endocarditis
Severe Aorta Regurgitation with signs of bi-ventricular failure Pulmonary edema with acute respiratory failure

8 Special investigation
Bloods: FBC : WCC 8.4, Hb 14.1, plt 191 U&E : Na 136, K 5.2, Urea 17.6, Cr 133 LFT : t-prot 72, alb 25, t-Billi 35, c-Billi 16, ALP 109, GGT 108, AST 165, ALT 293, LDH 150 CRP 5.2 Trop-T : negative, CK : normal ASOT negative, ANA negative, RF negative, RPR negative, HIV negative BC negative Cardiac echo CXR ECG

9 ECG

10 CXR

11 echo Aorta root diameter = 30 mm (normal)
Aorta valve opening = 21 mm (normal) Vegetation on all three aorta cusps Pressure half time = 67 ms (<200ms  severe acute AR) Mitral valve : mild regurgitation Left Atrium : 4.3 cm (enlarged) Left ventricle: LVEDD 6.5 cm, LVESD 5 cm, LVEF = 44% Right heart mildly enlarged, mild TI, RVPSP = 65 mmHg

12

13 Treatment Furosemide 40 mg bd ivi Enalapril 5 mg bd po
Elantin 20 mg bd po Pen G, Gentamycin, Cloxacillin, Diflucan Urgent cardio-thoracic consult Ross procedure was done

14 Surgery in NVE Introduction
1961 : Kay and colleagues excised fungal vegetation from tricuspid valve 1965 : AVR in IE due to Serratia Marcescens Last 3 decades : valve replacement/ repair common in Mx of complicated IE Decreased mortality in IE due to combination of antibiotics and timely surgical intervention

15 Indications 2006 American College of Cardiology/ American Heart Association (ACC/ AHA) Surgery is warranted for native valve IE who have one or more of the following 1. Heart failure (moderate to severe) that is directly related to valve dysfunction. 2. Severe aorta/ mitral regurgitation with evidence of abnormal hemodinamics, such as elevated LVED or left atrial pressures. 3. Endocarditis due to fungal of high resistant organisms. 4. Peri-valvular infection with abscess/ fistula formation

16 Other condition considered as possible indications
1. Embolic events while on appropriate antibiotic regimen or large vegetations (> 10mm in diameter) 2. Large vegetations > 10mm in diameter (even without embolic events) if mobile

17 Choice of procedure For active infection (2006 ACC/AHA):
Valve repair rather than replacement Only possible in minority of cases Thus leaflet perforation without destruction or annular involvement.

18 Heart Failure Moderate to severe HF due to IE
Medical therapy : mortality rate 75% Medical & surgical : mortality rate 25% HF is indication in 2/3 to ¾ of cases IE induced AR is more likely to produce HF than IE induced MR (death may occur suddenly in aorta involvement)

19 Caveats Non cardiac factors that exaggerate HF Hx of previous HF.
Fever, anemia, sepsis, renal insufficiency Hx of previous HF. HF out of proportion to valve dysfunction.

20 Complicated infection
Persistent positive BC 5 to 7 days or lack of clinical improvement after 1 week of appropriate Rx  search for metastatic abscess; then  Echocardiographic evidence of perivalvular abcess / fistula formation/ leaflet perforation Serial TEE and early  in presence of known difficult organism. New heart block

21 Fungal infection is in general an early indication for 
Relapse after adequate therapy may require  intervention. A 2nd course of antibiotics is only indicated if no perivalvular infection and offending organism is sensitive to Rx.

22 Embolization Overall risk : 13 – 44%
Decline after effective antimicrobial Rx, thus  not necessary to prevent stroke.  indicated after a second embolic event after appropriate Rx in patient with persistent vegetations. ‘Silent’ emboli, thus screen (CT scan) all patient with large (>1cm) or mobile vegetations prior to 

23 Emboli ( risk) Cardiopulmonary bypass and need for anticoagulation increases the risk of extending infarct and or converting a nonhemorrhagic infarct into a hemorrhagic lesion. Suggested  is postponed 2 weeks after cerebral infarction and 4 weeks after cerebral hemorrhage. May be done before 2 weeks if compelling indications (eg moderate HF).

24 Emboli (vegetation size)
Larger size  larger risk for emboli In general  is not indicated for increase in vegetation size in patient responding well to medical Rx Vegetations > 10mm by itself is not sufficient to require , unless other complicating features.

25 Timing of surgery Concern: placing prosthetic valve in actively infected tissue ! Recommendation:  should not be delayed with clear indications regardless of duration of pre-operative antibiotics.

26 Antibiotic following surgery
2004 European Society of Cardiology (ESC): Full course of antibiotic Rx if valve culture is positive If culture negative, complete full course counting the pre-operative duration of Rx. Minimum duration 7 to 15 days post operative. Rate of relapse 3/358

27 Reference Fauci, AS, Braunwald, E, Harrison’s Principles of Internal Medicine, 17th Edition, 2008 Schick, EC, Surgery for native valve endocarditis, Uptodate, June 2008 Talley, NJ, O’Conner, S, Clinical examination, 2001

28 Q & A Thank you


Download ppt "Valve Replacement in Infective Endocarditis"

Similar presentations


Ads by Google